AG05134/AG/NIA NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1986	5
1987	9
1988	8
1989	15
1990	7
1991	14
1992	19
1993	14
1994	14
1995	11
1996	19
1997	10
1998	9
1999	14
2000	8
2001	10
2002	12
2003	6
2004	9
2005	12
2006	9
2007	12
2008	14
2009	7
2010	3
2011	4
2012	3
2013	5
2014	3
2015	3
2016	1
2021	0

1

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ. Hyman BT, et al. Alzheimers Dement. 2012 Jan;8(1):1-13. doi: 10.1016/j.jalz.2011.10.007. Alzheimers Dement. 2012. PMID: 22265587 Free PMC article.

2

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT; National Institute on Aging; Alzheimer’s Association. Montine TJ, et al. Acta Neuropathol. 2012 Jan;123(1):1-11. doi: 10.1007/s00401-011-0910-3. Epub 2011 Nov 20. Acta Neuropathol. 2012. PMID: 22101365 Free PMC article.

3

Clinical manifestations of cerebral amyloid angiopathy-related inflammation.

Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Eng JA, et al. Ann Neurol. 2004 Feb;55(2):250-6. doi: 10.1002/ana.10810. Ann Neurol. 2004. PMID: 14755729

4

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.

Gómez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT. Gómez-Isla T, et al. Ann Neurol. 1997 Jan;41(1):17-24. doi: 10.1002/ana.410410106. Ann Neurol. 1997. PMID: 9005861

5

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.

Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RL. Dickerson BC, et al. Cereb Cortex. 2009 Mar;19(3):497-510. doi: 10.1093/cercor/bhn113. Epub 2008 Jul 16. Cereb Cortex. 2009. PMID: 18632739 Free PMC article.

6

New neuropathological criteria for Alzheimer disease.

Hyman BT. Hyman BT. Arch Neurol. 1998 Sep;55(9):1174-6. doi: 10.1001/archneur.55.9.1174. Arch Neurol. 1998. PMID: 9740109 Review. No abstract available.

7

Human brain cholinergic pathways.

Mesulam MM. Mesulam MM. Prog Brain Res. 1990;84:231-41. doi: 10.1016/s0079-6123(08)60908-5. Prog Brain Res. 1990. PMID: 2267300 Review. No abstract available.

8

Biomarkers of Alzheimer disease in plasma.

Irizarry MC. Irizarry MC. NeuroRx. 2004 Apr;1(2):226-34. doi: 10.1602/neurorx.1.2.226. NeuroRx. 2004. PMID: 15717023 Free PMC article. Review.

9

Mitochondria, free radicals, and neurodegeneration.

Beal MF. Beal MF. Curr Opin Neurobiol. 1996 Oct;6(5):661-6. doi: 10.1016/s0959-4388(96)80100-0. Curr Opin Neurobiol. 1996. PMID: 8937831 Review.

10

Molecular genetic approaches to Alzheimer's disease.

Tanzi RE, St George-Hyslop PH, Gusella JF. Tanzi RE, et al. Trends Neurosci. 1989 Apr;12(4):152-8. doi: 10.1016/0166-2236(89)90055-6. Trends Neurosci. 1989. PMID: 2470173 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results